Sanofi, J&J, Boehringer
Sanofi, J&J, Boehringer
10 FAMOUS PRODUCTS
Brief history:
BOEHRINGER INGELHEIM 3. Responsibility
Logo Since the founding of the company in 1885, they have been
MISSION: “Making new and better medicines for humans and driven by the desire to serve mankind. They aim to continue
animals is at the heart of what we do. Our mission is to create serving as a reliable partner through improving human and
breakthrough therapies that change lives.” animal health around the world. This company focuses in
human pharmaceuticals, animal health and biopharmaceutical
VISION: Their vision can be summed up in a few words; value contract manufacturing where they also have world leading
through innovation. technology and production capability. They are one of the
The company ‘s goal is to improve the health and quality of life pharmaceutical industries top 20 companies operating in more
of humans and animals through developing innovative than 150 countries and territories around the world. They are
therapies that can extend patients’ lives and provide advanced also one of the world's leading companies in the animal health
prevention on animal health. market. In japan, they have company there which is active for
more than 55 years. Their company is one of the Japan most
VALUES successful international pharmaceutical companies. Serving as
1. Care a reliable partner for human and animal health around the
They are known as caring company. All of their activities are world is their responsibility.
written with the word care. They are proud and delighted
showing a great pleasure to stand beside patients and their 4. Innovation
families contributing to their health and happiness. This They develop breakthrough therapies and healthcare solutions
company's greatest assets are their people who care. They in areas of unmet medical needs through their four research
focus on people development through diverse working and discovery sites around the world; in Germany, Australia,
practices. They promote diversity and inclusion through mutual US and Japan. They conduct clinical research and discovery
understanding over flexible approaches to work, gender, on global scale. They're also working to improve the
reducing working hours and various other initiatives. Therefore, productivity of global research making it possible to achieve
recognizing their people who share their values of compassion more efficient developments. In Japan, Kobe Pharma research
are their greatest asset. Institutes acts as a liaison to them. They reflect the needs of
the Japanese market into global discovery activities which
2. Independence harness Japan's advanced technology to develop formulations
This company has achieved sustainable growth for more than in their pipeline in the global research and discovery network.
133 years while maintaining its unique position as an Research and discovery driven pharmaceutical company for
independent and family-owned company. Through research breakthrough therapies and healthcare solutions what make
and discovery and business strategies with long-term them innovative or in innovation.
perspectives, they have achieved growth that exceeded the
global pharma market. They have also created a pipeline of
promising effective compounds which they hope that will serve
patients in the future. While maintaining their independent
research and discovery structures, they seek to continually
achieve open innovation by building appropriate partnerships
with other parties such as universities, science research
institutions and bioventure companies. So, this company
maintained their position as an independent company and
achieving sustainable growth.
BRIEF HISTORY 1. Micardis®, Micardis Plus® ( Telmisartan, Telmisartan
1. In 1885, Albert Boehringer (1861-1939) founded the + HCTZ) - It is anti-hypertensive drug which is a
pharmaceutical company Boehringer Ingelheim in Nieder- combination of angiotensin receptor II antagonists
Ingelheim, today a part of Ingelheim am Rhein. Since its and ties with diuretic used to treat high blood
beginnings in 1885 when it employed just 28 people, the pressure
company has become a global enterprise, with three business 2. Pradaxa® (Dabigatran etexilate) - It is a direct
areas: Human Pharma, Animal Health, and Biopharmaceutical thrombin inhibitor that is used in the treatment of
Contract Manufacturing. deep vein thrombosis or DVT and pulmonary
embolism.
2. Albert Boehringer purchases a small tartar factory in Nieder- 3. Combivent® (Ipratopium bromide + Salbutamol) - It
Ingelheim, today part of Ingelheim am Rhein. is indicated for use in patients with chronic
obstructive pulmonary disease or COPD. It is an
3. The first 28 employees manufactured tartaric acid salts used by inhalation aerosol.
pharmacies and dyeing works. Over the course of the next 4. Actilyse® (Alteplase) - It is used for fibrinolytic
decades, the once small tartar factory grew into a big therapy. It is used for treatment of heart attacks,
pharmaceutical company. Throughout this time, employee pulmonary embolism and stroke.
benefits became a cornerstone of the company’s identity, with 5. Jardiance® (Empagliflozin) - It is a sodium glucose
several initiatives launched at the beginning of the 20th co-transporter-2 inhibitor indicated to improve
century. Major breakthroughs and successes in research and glycemic control in type 2 diabetes mellitus.
development during the interwar period are closely tied to the 6. Trajenta® (Linagliptin) - It is indicated as an adjunct
activities of Heinrich Wieland and his brother Hermann to diet and exercise to improve glycemic control in
Wieland. In 1927, Heinrich Wieland was awarded the Nobel adults with type 2 diabetes mellitus.
Prize in Chemistry, an outstanding achievement which honored 7. Spriva® (Tiotoprium bromide) - It is indicated to
his research efforts that also contributed to the launch of reduce exacerbation in COPD patients including
several products for Boehringer Ingelheim. chronic bronchitis and emphysema.
8. Twynsta® (Telmisartan + Amlodipine ) - It is also an
4. By the time of Albert Boehringer’s death in 1939, the company antihypertensive drug used to lower blood pressure.
employed 1,500 people. His two sons Albert jr. and Ernst 9. Mobic® (Meloxicam) - It is also a non-steroidal anti-
Boehringer as well as his son-in-law Julius Liebrecht took over inflammatory indicated for relief of the signs and
the family company, having served on the company's Board of symptoms of rheumatoid arthritis.
Directors since the 1920s. 10. Dulcolax® (Bisacodyl) -It is used to treat
constipation.
Famous Products